Healthcare provider profile · identity verified

John B Eberly, M.D.

Family Practice · TAYLORS, SC · NPI 1093719320

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	508	141
Amlodipine Besylate	Amlodipine Besylate	487	133
Rosuvastatin Calcium	Rosuvastatin Calcium	376	94
Levothyroxine Sodium	Levothyroxine Sodium	323	78
Lisinopril	Lisinopril	285	82
Omeprazole	Omeprazole	255	68
Metoprolol Succinate	Metoprolol Succinate	190	53
Tamsulosin Hcl	Tamsulosin Hcl	180	48
Zolpidem Tartrate	Zolpidem Tartrate	174	31
Metformin Hcl	Metformin Hcl	166	50
Hydrochlorothiazide	Hydrochlorothiazide	135	45
Pravastatin Sodium	Pravastatin Sodium	132	37
Valsartan	Valsartan	122	32
Carvedilol	Carvedilol	121	39
Losartan Potassium	Losartan Potassium	113	27
Simvastatin	Simvastatin	110	31
Ezetimibe	Ezetimibe	92	25
Furosemide	Furosemide	85	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	23
Pantoprazole Sodium	Pantoprazole Sodium	82	21
Pioglitazone Hcl	Pioglitazone Hcl	81	24
Metoprolol Tartrate	Metoprolol Tartrate	74	16
Olmesartan Medoxomil	Olmesartan Medoxomil	74	26
Lorazepam	Lorazepam	72	18
Albuterol Sulfate Hfa	Albuterol Sulfate	70	35
Spironolactone	Spironolactone	69	24
Candesartan Cilexetil	Candesartan Cilexetil	68	17
Chlorthalidone	Chlorthalidone	67	23
Gabapentin	Gabapentin	65	18
Eliquis	Apixaban	64	13
Jardiance	Empagliflozin	64	20
Fluticasone Propionate	Fluticasone Propionate	63	29
Clonazepam	Clonazepam	62	suppressed
Ozempic	Semaglutide	62	suppressed
Indapamide	Indapamide	61	17
Alprazolam	Alprazolam	60	11
Naproxen	Naproxen	60	23
Irbesartan	Irbesartan	56	17
Montelukast Sodium	Montelukast Sodium	54	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	53	14
Clopidogrel	Clopidogrel Bisulfate	53	16
Potassium Chloride	Potassium Chloride	53	13
Telmisartan	Telmisartan	53	17
Escitalopram Oxalate	Escitalopram Oxalate	52	15
Trazodone Hcl	Trazodone Hcl	50	13
Duloxetine Hcl	Duloxetine Hcl	47	12
Ramipril	Ramipril	46	12
Meloxicam	Meloxicam	45	16
Metformin Hcl Er	Metformin Hcl	45	13
Tramadol Hcl	Tramadol Hcl	43	11
Allopurinol	Allopurinol	42	14
Sertraline Hcl	Sertraline Hcl	42	12
Testosterone Cypionate	Testosterone Cypionate	41	14
Benazepril Hcl	Benazepril Hcl	39	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	17
Trulicity	Dulaglutide	37	suppressed
Mounjaro	Tirzepatide	36	suppressed
Eszopiclone	Eszopiclone	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	35	suppressed
Glimepiride	Glimepiride	34	14
Triamcinolone Acetonide	Triamcinolone Acetonide	34	13
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Finasteride	Finasteride	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	11
Diclofenac Sodium	Diclofenac Sodium	31	14
Farxiga	Dapagliflozin Propanediol	30	suppressed
Pregabalin	Pregabalin	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Famotidine	Famotidine	28	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Synthroid	Levothyroxine Sodium	28	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Prednisone	Prednisone	25	21
Warfarin Sodium	Warfarin Sodium	25	suppressed
Cephalexin	Cephalexin	24	14
Estradiol	Estradiol	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	13
Enalapril Maleate	Enalapril Maleate	23	suppressed
Amoxicillin	Amoxicillin	22	20
Colesevelam Hcl	Colesevelam Hcl	21	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Rybelsus	Semaglutide	20	suppressed
Fluconazole	Fluconazole	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Diazepam	Diazepam	16	suppressed
Livalo	Pitavastatin Calcium	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Zypitamag	Pitavastatin Magnesium	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	11	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error